Culturally-Adapted Family Intervention Study (CaFI)

Culturally-adapted family intervention for African and Caribbean people diagnosed with psychosis, and their families.

Project background

Individuals with psychosis, who come from African and Caribbean backgrounds, are often provided with inadequate treatment.

The National Institute for Health and Care Excellence (NICE) recommends talking therapies like family intervention, to treat schizophrenia and psychosis. However, Sub-Saharan African and Caribbean people, including people of Mixed heritage, aren’t usually offered this type of treatment.

A research team led by Dr Dawn Edge at The University of Manchester piloted a new talking treatment, Culturally-adapted Family Intervention (CaFI), with Caribbean families. Service users with a schizophrenia diagnosis and their family members liked it and thought it helped them better cope with the illness. However, the study was too small to test if the treatment is ‘clinically effective’ (if it really works).

Based on this work, the National Institute for Health Research (NIHR) has funded a larger-scale study to assess whether CaFI can help service users and their families. This time, there are two main differences:

  1. CaFI was originally for families of Caribbean origin only. Now, people of Sub-Saharan African and Caribbean heritage will also be able to take part. This includes people who identify as Black British or Mixed heritage.
  2. The previous study was available to participants in Manchester only. This time, the new study will be available to people in Greater Manchester, Merseyside, London, Midlands and Southampton as opposed to just Manchester.
You can learn more about the first CaFI study in the video below. The video features short interviews with participants and the research team.

Project aims

This project has a number of different objectives.

Our main focus is on discovering whether CaFI is at least as good as usual care offered on the NHS, which most often consists of medication.

We also aim to:

  • Understand what helps and stops mental health service providers to offer CaFI 
  • Understand how to make best use of the things that help CaFI to be used regularly in services
  • Understand how we could overcome barriers to deliver CaFI in services
  • Find out if CaFI is good value for money

Timeline and process

Explore our timeline of what we aim to achieve across the next four and a half years.

0-12 months
  • Secure research ethics and other approvals
  • Set-up the participating research sites
  • Work with service users of Sub-Saharan and Caribbean origin, their relatives/carers/advocates and health professionals to refine CaFI and relevant materials
  • Therapist recruitment and training
  • Recruiting and training Family Support Members (‘FSMs’) who can support service users receive CaFI who have lost contact with family
13-24 months
  • Recruiting people to test CaFI
  • Making sure that CaFI is acceptable to both people of African and Caribbean descent
13-52 months
  • Recruiting more people to test CaFI
  • Delivering CaFI to family units
  • Collecting information before receiving CaFI
  • Collecting information directly after receiving CaFI
  • Collecting information 6 months after receiving CaFI
  • Collecting information 12 months after receiving CaFI
  • Analysing the collected information
43-54 months
  • Share findings with the public (including service users and families), health professionals. policy makers and academics
  • Deciding what to do next

Meet the research team

Our research team comprises research and healthcare experts from all over the country.

Manchester

Dr Dawn Edge: Senior Lecturer, Division of Psychology & Mental Health, at the University of Manchester. Dr Edge will lead the project, overseeing all aspects including setting up, data collection and analysis, dissemination, ethics and governance. She will supervise the trial manager and research assistants (RAs) and oversee coordination across all sites.

Professor Kathryn Abel: Professor of Psychiatry & Director of the Centre for Women’s Mental Health. Kathryn will provide expertise in schizophrenia, trial design and senior oversight of the trial.

Dr Lesley-Anne Carter: Lecturer at the University of Manchester. Dr Carter will provide expertise in trial design and statistics.

Dr Katherine Berry: Senior Clinical Lecturer and HCPC registered Consultant Clinical Psychologist. Dr Berry will contribute to trial design, refining the intervention and supporting materials, and therapists’ training.

Dr Richard Drake: Senior Lecturer/ Honorary Consultant Psychiatrist, at the University of Manchester.
Dr Drake will contribute expertise in trial design and evaluating psychosocial intervention in schizophrenia, including expertise in culturally-adaptation.

Professor Anthony Morrison: Professor of Clinical Psychology at the University of Manchester. In addition to expertise in trial design, Anthony will facilitate service access and contribute expertise in trialling psychological interventions.

Mr Paul Wilson: Senior Research Fellow at Alliance Manchester Business School and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Greater Manchester (NIHR CLAHRC GM).

Professor Linda Davies: Professor of Health Economics Research at the University of Manchester. Linda has experience in the economic evaluation of interventions for people with mental health problems and will provide expertise in health economics.

Ms Helen Wilson: Project & Trial Manager at Greater Manchester Mental Health NHS Foundation Trust. Helen’s role includes ensuring that the project is run smoothly in all sites, and that it is conducted according to all legal and ethical guidelines.

Dr Henna Lemetyinen: Research Associate at Greater Manchester Mental Health NHS Foundation Trust. Henna previously worked in Dr Edge’s Culturally-adapted Schizophrenia Psycho-Education Resource (CaSPER) project. Henna will support the day-to-day activities of the Manchester site.

London

Dr Claire Henderson: Consultant Psychiatrist at the Kings College London. Dr Henderson’s role in this project is to provide expertise in trial design and mental health related stigma and discrimination. Dr Henderson will be the site lead in London.

Dr Shublade Smith: Consultant Psychiatrist at the Kings College London. Dr Smith’s role in this project is to provide expertise in transcultural and forensic psychiatry and mental health policy.

Dr Louisa Codjoe: Psychologist at the Kings College London. Dr Codjoe’s role in this project is to provide expertise in transcultural psychology.

Midlands

Coventry & Warwickshire

Professor Swaran Singh: Head of Mental Health and Wellbeing at the University of Warwick. With a strong track record of multi-disciplinary collaboration and successful trials, Prof Singh will be site lead for the Midlands.

Nottingham (a reserve site)

Professor Gillian Doody: Dean of Medical Education at the University of Nottingham. Gillian will contribute expertise in psychosis and medical education. Her experience as member of the Aetiology and Epidemiology of Schizophrenia and Other Psychoses (AESOP) team will be invaluable. She will be site lead for Nottingham.

South

 

Southampton

Professor Shanaya Rathod: Visiting Professor, University of Portsmouth.  Shanaya’s role is to provide expertise in cultural adaptation and to be the site lead for Southern Health Care (Southampton).

Bristol (reserve site)

Dr Jonathan Evans: Consultant Senior Lecturer, Centre for Academic Mental Health, School of Population Health Sciences, Bristol Medical School, at the University of Bristol. As site lead in Bristol, Dr Evans will provide expertise in psychosis and liaison with clinical services. 

Collaborators

Reverend Paul Grey: Independent Service User Consultant and ‘expert by experience’. Rev Grey will provided invaluable insight from the service user perspective.

Ms Sonia Lindsay: Carer Consultant and ‘expert by experience’. A member of the RAG in our CaFI feasibility study, Ms Lindsay will provide expertise from the carer perspective.

Mrs Michelle Ayavoro: Community Member and activist. A member of the RAG in our CaFI feasibility study, she will be a community-focused Independent Consultant on this project.

Dr Josanne Holloway: Clinical Lead, Greater Manchester Mental Health NHS Foundation. Dr Holloway will facilitate access to services via clinical PI and community forensic services.

Dr Nicholas Jon Kennedy: Consultant Psychiatrist, Birmingham & Solihull Mental Health NHS Foundationb Trust. Dr Kennedy’s role will be to provide expertise in transcultural psychiatry and Clinical PI for Birmingham.

Dr Judith Richardson: Programme Director – Quality and Leadership, Health and Social Care, NICE. Dr Richardson will contribute expertise in Health Service Policy and service implementation.

Getting involved

There are a number of ways to get involved in this project, with a variety of roles on offer.

Whether you are a service user, a family member/carer, a community member, a health professional, a student or an academic, there is a part for you to play in this study.

If you would like to register your interest, please contact Project & Trial Manager Helen Wilson, or Research Associate Dr Henna Lemetyinen.

Henna Lemetyinen:

email: henna.lemetyinen@gmmh.nhs.uk
tel: 0161 276 5272
@cafistudy